Physician

Debra Babich, M.D.

According to 2025 Medicare claims, Debra Babich, M.D. (NPI: 1649215757) practices dermatology in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is VITALSKIN MEDICAL GROUP IL PLLC (NPI: 1063030252; TIN: 851790842) and primary practice location at 62526-3269. Babich is affiliated with the Medical Home Network Health Alliance I, LLC (ACO ID: A5518), participating under the MSSP model.

Babich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,159 traditional Medicare patients, billed 2,878 HCPCS/CPT codes, and received $141,894 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 996 prescription claims across 394 beneficiaries totaling $281,867 in drug costs, led by Tacrolimus (Tacrolimus). Open Payments data shows 86 records totaling $1,322. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $265,697 to $141,894. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $244,564 and ending at $281,867. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,397	6,610	$265,697
2016	2,429	7,001	$264,779
2017	2,365	6,930	$260,695
2018	2,289	6,457	$264,079
2019	2,268	6,116	$286,598
2020	2,153	5,029	$238,808
2021	2,085	4,800	$270,265
2022	1,206	2,406	$140,931
2023	971	2,131	$116,615
2024	1,159	2,878	$141,894

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	453	1,192	$244,564
2016	468	1,294	$166,309
2017	344	852	$86,862
2018	342	842	$141,388
2019	342	801	$247,654
2020	275	708	$144,189
2021	301	747	$185,978
2022	324	721	$229,089
2023	304	766	$245,495
2024	394	996	$281,867

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	324	391	$76
17110	Destruction of skin growth, 1-14 growths	131	144	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	707	808	$51
17000	Destruction of precancer skin growth, 1 growth	204	239	$35
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	198	230	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tacrolimus	Tacrolimus	31	795	$3,623
Fluorouracil	Fluorouracil	48	1,396	$3,574
Doxycycline Monohydrate	Doxycycline Monohydrate	139	4,863	$2,896
Mometasone Furoate	Mometasone Furoate	123	3,057	$1,643
Metronidazole	Metronidazole	31	829	$1,508

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	86	$1,322	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Debra Babich, M.D.?

Tedicare shows public-source Medicare data for Debra Babich, M.D. (NPI 1649215757), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Debra Babich, M.D. have ACO affiliation data?

Debra Babich, M.D. is shown with ACO affiliation data for Medical Home Network Health Alliance I, LLC (MSSP, ACO ID A5518).

What billing organization is linked to Debra Babich, M.D.?

Debra Babich, M.D. is linked to VITALSKIN MEDICAL GROUP IL PLLC (billing NPI 1063030252) in the available physician profile data.

Does Debra Babich, M.D. have Open Payments data?

Debra Babich, M.D. has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.